ARCHIVES

Chabner, FDA’s Temple continue disagreement Over Drug Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 06 | February 10, 1989

Download PDF Visit The Full Archive

Related Articles

Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal

July 27, 2001

Upon, Panel Lean To Anecdotal Laetrile Study

August 12, 1977

NCI Letter to HCFA Outlines Positions, Offers Glimpse of Tactics

September 27, 1996

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978